LINC02723

Across TCGA pan-cancer cohorts, LINC02723 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of LINC02723’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC02723 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02723 is over-expressed in tumor, although a few such as COAD and LUSC show the opposite, repressed pattern.

COAD, LUSC, and LIHC are the cancer types where LINC02723 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02723 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	−0.242	<.001	10	view →
LUSC	Male	II,III,IV	−0.434	<.001	8	view →
LIHC	Male	III,IV	−0.250	<.001	7	view →
KICH	All	All	−0.809	<.001	6	view →
UCEC	All	III,IV	−0.502	.002	6	view →
BLCA	All	All	−0.153	.022	5	view →
PAAD	All	All	−0.762	.001	4	view →
THCA	All	II,III,IV	+0.190	.002	4	view →
BRCA	All	II,III,IV	−0.104	.007	4	view →
PRAD	All	All	−0.125	.042	2	view →
ESCA	Female	All	+0.070	.010	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

LINC02723–COAD

Open the COAD breakdown →